Key facts
- This page summarizes Daniel M. Junius's Form 4 filing for IDEXX LABORATORIES INC /DE (IDXX).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 07 Dec 2022, 15:30.
Daniel M. Junius - 05 Dec 2022 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)
- Reporting relationship
- Director
- Issuer ticker
- IDXX
- Reported as of
- 05 Dec 2022
- Net transaction value
- -$806,063
- SEC form
- 4
- Accepted by SEC
- 07 Dec 2022, 15:30:49 UTC
- Prior SEC filing
- 18 Nov 2022
- Next SEC filing
- 01 Feb 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Lily J. Lu, Attorney-in-Fact for Daniel M. Junius
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Daniel M. Junius filed Form 4 for IDEXX LABORATORIES INC /DE (IDXX) on 07 Dec 2022.
Change
- Previous filing in this sequence was filed on 18 Nov 2022.
- Current net transaction value: -$806,063.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IDXX
transaction
Common Stock
Options Exercise
- Transaction value
- $488,213
- Shares
- +3,046
- Change %
- +103%
- Price
- $160.28
- Shares after
- 6,014
- Date
- 05 Dec 2022
- Ownership
- Direct
IDXX
transaction
Common Stock
Sale
- Transaction value
- $1,294,276
- Shares
- -3,046
- Change %
- -51%
- Price
- $424.91
- Shares after
- 2,968
- Date
- 05 Dec 2022
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IDXX
transaction
Derivative
Non-Qualified Stock Option (right-to-buy)
Options Exercise
- Transaction value
- Shares
- -3,046
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 05 Dec 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,046
- Exercise price
- $160.28
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Grant of option to buy 3,046 shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the one year anniversary of the date of grant or on the date of the 2018 annual meeting of shareholders, whichever event was earlier.
Footnote F2
Not applicable.